Author: FinSiddhi

QIAGEN receives FDA clearance for bloodstream infection test

Indian banks have sought RBI approval to spread mark-to-market losses on investment portfolios across the remaining three quarters, citing bond-market volatility triggered by the West Asia crisis. Rising government bond yields have weighed sharply on banks’ treasury income.

The ISL’s media rights value has fallen from ₹275 crore a year paid by JioStar to ₹8.6 crore offered by FanCode for the 2025-26 season. JioStar had bid ₹5 crore for the property. FanCode and Sony Sports Network broadcast the league after intervention by the sports ministry helped facilitate the staging of the season, with…

GoPro reports Q2 revenue of $105M, net loss widens to $51M

SAIHEAT to merge with Canopy Wave in $100M AI deal

Sun Pharma recalled eleven eyecare products after an eye specialists’ body issued a safety alert. This alert warned about bacterial contamination found in certain batches of their Predmet eyedrop medicine. The All India Ophthalmological Society stressed patient safety due to potential serious ocular infection risks. Sun Pharma stated the recall was a precautionary measure while…

Proficient Auto Logistics stock falls 12% on $130M acquisition

Dollar rises after two-week losing streak, yen gives up more intervention gains

HighPeak Energy surges over 6% after hours on blowout Q2 earnings report

<a href=”https://timesofindia.indiatimes.com/india/govt-offers-amit-shah-statement-in-parliament-opposition-doesnt-relent/articleshow/133135487.cms”><img border=”0″ hspace=”10″ align=”left” style=”margin-top:3px;margin-right:5px;” src=”https://timesofindia.indiatimes.com/photo/133135487.cms” /></a>